Literature DB >> 19609952

Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology.

Delphine Maucort-Boulch1, Martyn Plummer, Philip E Castle, Franklin Demuth, Mahboobeh Safaeian, Cosette M Wheeler, Mark Schiffman.   

Abstract

We investigated short-term persistence of human papillomavirus (HPV) infection among 2,408 women with low-grade or equivocal cytological abnormalities followed for 24 months. Odds ratios (ORs) for persistence to the next 6-month visit were estimated by a discrete time survival model. Prevalent HPV infections persisted longer in older women, but no association with age was found for incident HPV infections. Increased likelihood of persistence was found among current smokers of >20 cigarettes per day compared with smokers of <or=10 cigarettes per day (OR=1.43; 95% confidence interval [CI]: 1.02-2.01) and among current injectable contraceptive users (OR=1.15; 95% CI: 1.01-1.32). Persistence was more likely among infections with higher viral load (OR=2.05; 95% CI: 1.65-2.53) or with concurrent cytological abnormalities (OR=1.19; 95% CI: 1.03-1.39 and 1.29; 95% CI: 0.99-1.70 for ASCUS/LSIL and ASC-H/HSIL, respectively). We conclude that new HPV infections in older women are not riskier by the metric of viral persistence than those in younger women. Other risk factors such as oral contraceptive use and multiparity that have been associated with cervical cancer or cervical intraepithelial neoplasia grade 3 were not associated with short-term HPV persistence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19609952     DOI: 10.1002/ijc.24752

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

2.  Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.

Authors:  Julia C Gage; Hormuzd A Katki; Mark Schiffman; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Philip E Castle; Walter K Kinney
Journal:  Int J Cancer       Date:  2014-09-02       Impact factor: 7.396

3.  Discrete-time semi-Markov modeling of human papillomavirus persistence.

Authors:  C E Mitchell; M G Hudgens; C C King; S Cu-Uvin; Y Lo; A Rompalo; J Sobel; J S Smith
Journal:  Stat Med       Date:  2011-05-03       Impact factor: 2.373

Review 4.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna M Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers; David Chelmow; Abbe Herzig; Jane J Kim; Walter Kinney; W Lawson Herschel; Jeffrey Waldman
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

5.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

Review 6.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

7.  Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.

Authors:  Karin Sundström; Alexander Ploner; Lisen Arnheim Dahlström; Juni Palmgren; Joakim Dillner; Hans-Olov Adami; Nathalie Ylitalo; Pär Sparén
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-15       Impact factor: 4.254

8.  The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.

Authors:  Anne F Rositch; Michelle I Silver; Anne Burke; Raphael Viscidi; Kathryn Chang; Cindy M P Duke; Wen Shen; Patti E Gravitt
Journal:  J Low Genit Tract Dis       Date:  2013-01       Impact factor: 1.925

Review 9.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

10.  HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.

Authors:  Patricia Luhn; Nicolas Wentzensen
Journal:  Curr Obstet Gynecol Rep       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.